Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Research and Development Center, Zeon Corporation, Toyama, Japan.
Gastrointest Endosc. 2021 Nov;94(5):999-1008.e1. doi: 10.1016/j.gie.2021.06.014. Epub 2021 Jun 25.
EUS-guided hepaticogastrostomy (EUS-HGS) is associated with high rates of adverse events. The present study evaluated the feasibility of a newly designed stent equipped with a dilatation and antimigration system for EUS-HGS in phantom and animal models.
The newly designed stent was a partially covered laser-cut stent with antimigration anchoring hooks and a thin tapered tip (7.2F). The feasibility of these stents for biliary obstruction was compared with that of conventional stents. Evaluated outcomes were resistance force to migration in phantom and ex vivo models, rates of technical success and adverse events, and histology in an in vivo model.
The resistance forces on the distal (3.59 vs 1.73 N and 6.21 vs 1.74 N) and proximal (3.58 vs 1.5 N and 5.97 vs 1.67 N) sides in phantom and ex vivo models were significantly higher for hook stents than for conventional stents. Although EUS-HGS was successfully performed in all cases with both stents (100% [10/10] vs 100% [8/8]), the success rate of EUS-HGS without using a fistulous tract dilation device was significantly higher with hook stents (100% [10/10]) than with conventional stents (13% [1/8]). No adverse events occurred with either stent. Pathologic examination showed adhesion between the stomach and liver.
The strong resistance to migration and the absence of the dilation step are important advantages of newly designed hook stents. These stents may therefore be feasible and safe for EUS-HGS.
超声内镜引导下肝胃吻合术(EUS-HGS)相关的不良事件发生率较高。本研究评估了一种新设计的支架在体模和动物模型中应用于 EUS-HGS 的可行性,该支架配备了扩张和抗迁移系统。
新设计的支架是一种部分覆盖的激光切割支架,带有抗迁移锚固钩和一个薄的锥形尖端(7.2F)。比较了这些支架在胆道梗阻中的可行性与传统支架。评估的结果是在体模和离体模型中的迁移阻力、技术成功率和不良事件发生率以及在活体模型中的组织学。
在体模和离体模型中,支架远端(3.59 与 1.73 N 和 6.21 与 1.74 N)和近端(3.58 与 1.5 N 和 5.97 与 1.67 N)的阻力显著高于钩支架,而传统支架的阻力显著高于钩支架。尽管两种支架均成功完成了所有病例的 EUS-HGS(100%[10/10]与 100%[8/8]),但无瘘道扩张装置的 EUS-HGS 成功率显著高于钩支架(100%[10/10])高于传统支架(13%[1/8])。两种支架均未发生不良事件。病理检查显示胃和肝之间存在粘连。
新设计的钩支架具有较强的抗迁移能力和无需扩张步骤,这是其重要优势。因此,这些支架可能适用于 EUS-HGS,并且是安全的。